Rima Al-awar
Direktor/Vorstandsmitglied bei SATELLOS BIOSCIENCE INC.
Vermögen: - $ am 30.04.2024
Profil
Rima Al-awar is currently the Director at Satellos Bioscience, Inc. and has been a Member at Ontario Institute for Cancer Research since 2008.
She holds a doctorate degree from North Carolina State University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SATELLOS BIOSCIENCE INC
-.--% | 29.05.2023 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Rima Al-awar
| Unternehmen | Position | Beginn |
|---|---|---|
| SATELLOS BIOSCIENCE INC. | Direktor/Vorstandsmitglied | 05.12.2021 |
Ontario Institute for Cancer Research
 Ontario Institute for Cancer Research Hospital/Nursing ManagementHealth Services Ontario Institute for Cancer Research provides research on the prevention, early detection, diagnosis, and treatment of cancer. It offers Innovation programs, like cancer stem cell, innovation in target validation, and smarter imaging, Technology programs, like drug discovery, genome technologies, informatics and bio-computing, imaging translation, and tranformative pathology, and Translation programs. The company was founded by Calvin R. Stiller in December 2005 and is headquartered in Toronto, Canada. | Corporate Officer/Principal | 01.01.2008 |
Ausbildung von Rima Al-awar
| North Carolina State University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SATELLOS BIOSCIENCE INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Ontario Institute for Cancer Research
Ontario Institute for Cancer Research Hospital/Nursing ManagementHealth Services Ontario Institute for Cancer Research provides research on the prevention, early detection, diagnosis, and treatment of cancer. It offers Innovation programs, like cancer stem cell, innovation in target validation, and smarter imaging, Technology programs, like drug discovery, genome technologies, informatics and bio-computing, imaging translation, and tranformative pathology, and Translation programs. The company was founded by Calvin R. Stiller in December 2005 and is headquartered in Toronto, Canada. | Health Services |
